Intracerebral Hemorrhage Surgical Devices Segmentation
The global intracerebral hemorrhage surgical devices market is segmented by surgery type into open craniotomy, decompressive craniectomy, neuro endoscopy, and others, out of which, the open craniotomy segment is anticipated to hold the notable share in the market during the forecast period as it is the most studied and performed surgery. Although open craniotomy has a lot of exposure to brain cells, benefits, such as, rapid recovery time and less tissue scarring, make it the most common surgery for intracerebral hemorrhage.
Our in-depth analysis of the global market includes the following segments
|
By Surgery Type
|
|
|
By End-User |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of intracerebral hemorrhage surgical devices is evaluated at USD 1.92 billion.
Intracerebral Hemorrhage Surgical Devices Market size was over USD 1.82 billion in 2024 and is poised to exceed USD 4.23 billion by 2037, growing at over 6.7% CAGR during the forecast period i.e., between 2025-2037.
North America industry is expected to dominate majority revenue share by 2037, on the back of rising healthcare expenditure and investment in R&D activities, along with the presence of major market players in the region.
The major players in the market are Stryker Corporation, Abbott Laboratories, General Electric Company, Johnson & Johnson Services, Inc., Terumo Corporation, Becton, Dickinson and Company, and others.
